![Cynthia L. Grosskreutz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cynthia L. Grosskreutz
Direttore/Membro del Consiglio presso ONL Therapeutics, Inc.
Profilo
Cynthia L.
Grosskreutz has a current job as a Director at ONL Therapeutics, Inc.
Posizioni attive di Cynthia L. Grosskreutz
Società | Posizione | Inizio |
---|---|---|
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- Cynthia L. Grosskreutz